Results Snapshot
Figures in Cr
Standalone Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 14.61% vs -26.69% in Mar 2024
Standalone Net Profit
YoY Growth in year ended Mar 2025 is 147.14% vs -294.77% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 8.08% vs -31.52% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -6.00% vs 69.02% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has fallen from Mar 2024
Compare Annual Results Of Bajaj Healthcare With
Figures in Cr
Standalone Annual Results
Change(INR)
Change(%)
Net Sales
542.60
407.83
134.77
33.05%
Other Operating Income
0.00
0.00
0.00
Total Operating income
542.60
407.83
134.77
33.05%
Raw Material Cost
307.11
191.67
115.44
60.23%
Purchase of Finished goods
0.00
6.05
-6.05
-100.00%
(Increase) / Decrease In Stocks
-20.66
-2.70
-17.96
-665.19%
Employee Cost
57.06
57.55
-0.49
-0.85%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
116.66
81.00
35.66
44.02%
Total Expenditure (Excl Depreciation)
460.17
333.57
126.60
37.95%
Operating Profit (PBDIT) excl Other Income
82.43
74.26
8.17
11.00%
Other Income
19.40
20.08
-0.68
-3.39%
Operating Profit (PBDIT)
101.83
94.34
7.49
7.94%
Interest
27.90
10.66
17.24
161.73%
Exceptional Items
-3.43
0.00
-3.43
Gross Profit (PBDT)
73.93
83.68
-9.75
-11.65%
Depreciation
27.92
12.92
15.00
116.10%
Profit Before Tax
46.01
70.76
-24.75
-34.98%
Tax
3.08
23.09
-20.01
-86.66%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
42.93
47.67
-4.74
-9.94%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
-3.43
0.00
-3.43
Net Profit
39.50
47.67
-8.17
-17.14%
Equity Capital
15.79
38.21
-22.42
-58.68%
Face Value
5.00
1.00
0.00
Reserves
450.37
521.45
-71.08
-13.63%
Earnings per share (EPS)
12.51
1.25
11.26
900.80%
Diluted Earnings per share
13.10
1.41
11.69
829.08%
Operating Profit Margin (Excl OI)
15.19%
18.21%
0.00
-3.02%
Gross Profit Margin
13.63%
20.52%
0.00
-6.89%
PAT Margin
7.91%
11.69%
0.00
-3.78%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 542.60 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 14.61% vs -26.69% in Mar 2024
Annual - Standalone Net Profit
Standalone Net Profit 39.50 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 147.14% vs -294.77% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 82.43 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 8.08% vs -31.52% in Mar 2024
Annual - Interest
Interest 27.90 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -6.00% vs 69.02% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 15.19%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has fallen from Mar 2024






